Section 7.1 Laboratory
Laboratory Report #14
Date
Collection Date: October 13, 2021
Report Date: October 19, 2021
Laboratory
Labcorp
Ordering Physician
Dr. Billy R. Boring, Jr.
Report Type
Blood Culture Evaluation
Laboratory testing included:
- Blood Culture, Routine
Original Report
PDF: Labcorp – October 13, 2021 (Blood Culture)
One-Page Summary
Purpose of Testing
This laboratory evaluation was performed as part of the extensive diagnostic investigation during the peak of the systemic inflammatory illness in October 2021. Because significant inflammation can result from either infectious or non-infectious causes, blood cultures were obtained to determine whether a bacterial bloodstream infection could explain the elevated inflammatory markers and systemic symptoms.
Major Finding
Blood Culture
Result
- No aerobic growth
- No anaerobic growth
- Final Result: Negative
The culture was observed for five days before final reporting.
Interpretation
The blood culture was negative, demonstrating no laboratory evidence of bacterial bloodstream infection at the time of testing.
This finding was clinically important because the October 2021 evaluation showed significant systemic inflammation:
- ESR: 71 mm/hr
- CRP: 32 mg/L
- Progressive normocytic anemia
A negative blood culture helped physicians narrow the differential diagnosis by making a serious bacterial bloodstream infection less likely.
Overall Interpretation
This focused laboratory report provides an important diagnostic conclusion during the peak inflammatory period. Although the body was demonstrating significant systemic inflammation, the absence of bacterial growth in blood cultures indicated that the inflammatory process was unlikely to be caused by a detectable bloodstream bacterial infection.
When considered with the October 13, 2021 comprehensive evaluation, which also showed:
- Markedly elevated ESR and CRP
- Normocytic anemia
- Hyponatremia
- Negative urine culture
- Normal muscle injury markers
the findings supported continued investigation into inflammatory or autoimmune causes rather than bacterial infection.
Longitudinal Significance
This report contributes to:
- Systemic Inflammatory Illness Timeline
- Infectious Disease Evaluation
- Differential Diagnosis Archive
- Rheumatology Evaluation
It documents one of the key diagnostic exclusions during the most severe inflammatory period.
Clinical Importance
⭐⭐⭐ Important Diagnostic Exclusion
Although this report contains only one laboratory test, it is significant because it helped eliminate a major alternative explanation for the severe inflammation observed in October 2021.
Key Finding
- Blood Culture: Negative
- No aerobic bacterial growth.
- No anaerobic bacterial growth.
- Bloodstream infection not identified.
Related Reports
- August 31, 2021 – Initial Systemic Inflammatory Evaluation
- September 7, 2021 – Inflammation Follow-up
- October 13, 2021 – Peak Systemic Inflammatory Evaluation
- Urine Culture Evaluation
- Autoimmune Evaluation
- Rheumatology Consultation Summary
- Medical History Timeline
Navigation
- Previous Report: October 13, 2021 – Comprehensive Systemic Inflammatory Evaluation
- Next Report: Additional 2021 Inflammatory Follow-up Laboratory Reports
- Return to Laboratory Library
- Return to Health Inventory
Observation
This report is a good example of why the Laboratory Library should preserve all clinically meaningful laboratory studies, not just large panels. The value of this report is not in the number of tests performed, but in the question it answered:
“Was this severe inflammatory episode caused by a bacterial bloodstream infection?”
The answer was no.
Together with the other October 2021 findings, this negative culture helped direct the medical investigation toward the inflammatory and autoimmune pathway that became central to your diagnosis and recovery.